208 related articles for article (PubMed ID: 26751412)
21. Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.
Hsu LH; Hsu PC; Liao TL; Feng AC; Chu NM; Kao SH
BMC Cancer; 2016 Jul; 16():463. PubMed ID: 27411914
[TBL] [Abstract][Full Text] [Related]
22. Healthcare Costs and Utilization among Patients Hospitalized for Malignant Pleural Effusion.
Shafiq M; Ma X; Taghizadeh N; Kharrazi H; Feller-Kopman DJ; Tremblay A; Yarmus LB
Respiration; 2020; 99(3):257-263. PubMed ID: 32155630
[TBL] [Abstract][Full Text] [Related]
23. Palliative treatment of malignant pleural effusions by video-assisted thoracoscopic surgery.
Benkó I; Molnár TF; Horváth OP
Acta Chir Hung; 1999; 38(2):131-3. PubMed ID: 10596313
[TBL] [Abstract][Full Text] [Related]
24. [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases].
Martínez Moragón E; Aparicio Urtasun J; Sanchis Aldás J; Fullana Monllor J; Sanchis Moret F; Montalar Salcedo J; Marco Martínez V
Med Clin (Barc); 1993 Jul; 101(6):201-4. PubMed ID: 8332018
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.
Psallidas I; Kanellakis NI; Gerry S; Thézénas ML; Charles PD; Samsonova A; Schiller HB; Fischer R; Asciak R; Hallifax RJ; Mercer R; Dobson M; Dong T; Pavord ID; Collins GS; Kessler BM; Pass HI; Maskell N; Stathopoulos GT; Rahman NM
Lancet Oncol; 2018 Jul; 19(7):930-939. PubMed ID: 29908990
[TBL] [Abstract][Full Text] [Related]
26. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
[TBL] [Abstract][Full Text] [Related]
27. Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions.
Hunt BM; Farivar AS; Vallières E; Louie BE; Aye RW; Flores EE; Gorden JA
Ann Thorac Surg; 2012 Oct; 94(4):1053-7; discussion 1057-9. PubMed ID: 22513274
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches.
Lombardi G; Zustovich F; Nicoletto MO; Donach M; Artioli G; Pastorelli D
Am J Clin Oncol; 2010 Aug; 33(4):420-3. PubMed ID: 19858695
[TBL] [Abstract][Full Text] [Related]
30. Survival Difference in Patients with Malignant Pleural Effusions Treated with Pleural Catheter or Talc Pleurodesis.
Liou DZ; Serna-Gallegos D; Chan JL; Borgella J; Akhmerov S; Soukiasian HJ
Am Surg; 2016 Oct; 82(10):995-999. PubMed ID: 27779992
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
Chella A; Ribechini A; Dini P; Adamo C; Mussi A; Angeletti CA
Minerva Chir; 1994 Nov; 49(11):1077-82. PubMed ID: 7708227
[TBL] [Abstract][Full Text] [Related]
32. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
[TBL] [Abstract][Full Text] [Related]
33. Pleuroscopic Pleurodesis Combined With Tunneled Pleural Catheter for Management of Malignant Pleural Effusion: A Prospective Observational Study.
Boujaoude Z; Bartter T; Abboud M; Pratter M; Abouzgheib W
J Bronchology Interv Pulmonol; 2015 Jul; 22(3):237-43. PubMed ID: 26165894
[TBL] [Abstract][Full Text] [Related]
34. Rapid pleurodesis in symptomatic malignant pleural effusion.
Yildirim E; Dural K; Yazkan R; Zengin N; Yildirim D; Gunal N; Sakinci U
Eur J Cardiothorac Surg; 2005 Jan; 27(1):19-22. PubMed ID: 15621465
[TBL] [Abstract][Full Text] [Related]
35. Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases.
Martínez-Moragón E; Aparicio J; Sanchis J; Menéndez R; Cruz Rogado M; Sanchis F
Respiration; 1998; 65(2):108-13. PubMed ID: 9580921
[TBL] [Abstract][Full Text] [Related]
36. Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
Tomoda C; Ogimi Y; Saito F; Masaki C; Akaishi J; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K
Endocr J; 2016; 63(3):257-61. PubMed ID: 26655349
[TBL] [Abstract][Full Text] [Related]
37. Recurrent pleural effusion: who benefits from a tunneled pleural catheter?
Schneider T; Reimer P; Storz K; Klopp M; Pfannschmidt J; Dienemann H; Hoffmann H
Thorac Cardiovasc Surg; 2009 Feb; 57(1):42-6. PubMed ID: 19169996
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients.
Hirata T; Yonemori K; Hirakawa A; Shimizu C; Tamura K; Ando M; Katsumata N; Tanimoto M; Fujiwara Y
Eur Respir J; 2011 Dec; 38(6):1425-30. PubMed ID: 21565923
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance.
Popowicz N; Cheah HM; Gregory C; Miranda A; Dick IM; Lee YCG; Creaney J
PLoS One; 2021; 16(4):e0250628. PubMed ID: 33901252
[TBL] [Abstract][Full Text] [Related]
40. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
Clive AO; Kahan BC; Hooper CE; Bhatnagar R; Morley AJ; Zahan-Evans N; Bintcliffe OJ; Boshuizen RC; Fysh ET; Tobin CL; Medford AR; Harvey JE; van den Heuvel MM; Lee YC; Maskell NA
Thorax; 2014 Dec; 69(12):1098-104. PubMed ID: 25100651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
